glp journey retatrutide Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA 🎙️ NEW EPISODE: Retatrutide—The Triple

The complete 7-Day GLP-1 meal plan gives you the full structure, recipes, shopping list, and protein targets

The amount of weight lost was the same for the participants taking GLP-1s or other weight loss drugs

Medical teams may review meal size, hydration, constipation, reflux triggers, and symptom timing

CrossRef A Comprehensive Insight Into the Roles of Exosomal circRNAs in Metabolic Syndrome Azadeh Taherpour, Safieh Ebrahimi, Farshad Mirzavi BioFactors.2025;[Epub] CrossRef Basic and Translational Research Glucagon-Like Peptide-1 and Hypothalamic Regulation of Satiation: Cognitive and Neural Insights from Human and Animal Studies Joon Seok Park, Kyu Sik Kim, Hyung Jin Choi Diabetes Metab J

Major Findings: Demonstrated an acceptable safety and tolerability profile

The most common side effects for both injectable and oral forms of semaglutide (Wegovy) include gut issues, such as nausea, vomiting, diarrhea, and constipation, said Hamlet Gasoyan, PhD, assistant professor of medicine at Cleveland Clinic Lerner College of Medicine